Schedule 13G ownership disclosure
Intellipharmaceutics International Inc.
Security class unavailable · CUSIP: 458173309
Event date: 2018-10-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 239,943
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-18-004240
- Form type
- SC 13G
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- Nov 30, 2018
- Reporting period
- Oct 12, 2018
- Description
- Schedule 13G beneficial ownership